[ad_1] David Einhorn’s hedge fund Greenlight Capital picked up a new stake in Kenvue Inc.…
Tag:
Johnson & Johnson
-
-
[ad_1] A record number of people in the U.S. will turn 65 this year. Here’s…
-
STOCK MARKET
Kenvue’s stock slides 5.8% as J&J spinoff’s revenue and guidance fall short of expectations
by userby user[ad_1] Kenvue Inc.’s stock fell 5.8% at the closing bell on Thursday, after the consumer-health…
-
STOCK MARKET
J&J, Merck and Bristol Myers CEOs, under fire on Capitol Hill, seek to turn up heat on drug-market middlemen
by userby user[ad_1] Drugmakers grilled on the cost of prescription drugs on Capitol Hill Thursday sought to…
-
STOCK MARKET
Johnson & Johnson’s earnings beat estimates with boost from medical-technology sales
by userby user[ad_1] Johnson & Johnson posted stronger-than-expected earnings for the fourth quarter early Tuesday and offered…
-
STOCK MARKET
Kenvue’s stock rises after favorable court ruling in Tylenol litigation
by userby user[ad_1] Shares of Kenvue Inc. KVUE, +4.02% gained nearly 5% Tuesday morning after a federal…
-
STOCK MARKET
Why a derailed $11 trillion corporate bond market looks ripe for a comeback as U.S. inflation slows
by userby user[ad_1] Slowing U.S. inflation has sparked hopes of a big turnaround for hard-hit parts of…
-
STOCK MARKET
Johnson & Johnson beats earnings estimates and downplays obesity drugs’ impact on its med-tech business
by userby user[ad_1] Johnson & Johnson on Tuesday posted better-than-expected third-quarter earnings and raised its profit guidance…
-
[ad_1] While the current deal landscape on Wall Street remains low on M&A, initial public…
-
STOCK MARKET
Medicare drug price negotiations move forward with all drugmakers participating, White House says
by userby user[ad_1] All of the primary manufacturers of the 10 drugs selected in August for Medicare…